Novartis Investigative Site

Okmeydanı 34370

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early
• A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines — Completed